DNA-synthesis enzyme activity: A biological tool useful for predicting anti-metabolic drug sensitivity in breast cancer?

International Journal of Cancer

Volumn 74, Issue 2, 1997, Pages 156-161

  Romain, Sylvie ^a   Martin, Pierre Marie ^a   Klijn, Jan G M ^b   Van Putten, Wim L J ^b   Look, Maxime P ^b   Guirou, Olivier ^a   Foekens, John A ^b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; PROTEIN TYROSINE KINASE; THYMIDINE KINASE; THYMIDYLATE SYNTHASE;

ADULT; ARTICLE; BREAST CANCER; DNA SYNTHESIS; DRUG SENSITIVITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROTEIN-TYROSINE KINASES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; THYMIDINE KINASE; THYMIDYLATE SYNTHASE;

EID: 0030999570     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970422)74:2<156::AID-IJC3>3.0.CO;2-Y     Document Type: Article

References (21)

1. BARLOW, R.E., BARTHOLOMEW, D.J., BREMNER, J.M. and BRUNK, H.D., Statistical interference under order restrictions, John Wiley, London (1972).
2. BOLLA, M., ROSTAING-PUISSANT, B., CHEDIN, M., SULVIGNET, C., MARRON-CHARRIERE, J., COLONNA, M., BERLAND, E. and CHAMBAZ, E.M., Protein-tyrosine-kinase activity as a prognostic parameter in human breast cancer. Breast Cancer Res. Treat., 26, 283-287 (1993).
3. CLARK, G.M., DRESSLER, L.G., OWENS, M.A., POUNDS, G., OLDAKER, T. and MCGUIRE, W.L., Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. New Engl. J. Med., 320, 627-633 (1989).
4. CLAYTON, F., Pathologic correlates of survival in 378 lymph-node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor. Cancer, 68, 1309-1317 (1991).
5. EORTC BREAST CANCER COOPERATIVE GROLIP, Revision of the standards for the assessment of hormone receptors in human breast cancer. Europ. J. Cancer. 16, 1513-1515 (1980).
6. FOEKENS, J.A., PORTENGEN, H., VAN PUTTEN, W.L.J., PETERS, H.A., KRIJNEN, H.L.J.M., ALEXIEVA-FIGUSCH, J. and KLIJN, J.G.M., Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in breast-cancer cytosols. Cancer Res., 49, 5823-5828 (1989a).
7. FOEKENS, J.A., PORTENGEN, H., VAN PUTTEN, W.L.J., TRAPMAN, A.M.A.C., REUBI, J.C., ALEXIEVA-FIGUSCH, J. and KLIJN, J.G.M., Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res., 49, 7002-7009 (1989b).
8. HENNIPMAN, A., VAN OIRSCHOT, B.A., SMITS, J., RIJKSEN, G. and STAAL, G.E.L., Tyrosine-kinase activity in breast cancer, benign breast disease and normal breast tissue. Cancer Res., 49, 516-521 (1989).
9. JOHNSTON, P.G., FISHER, E.R., ROCKETTE, H.E., FISHER, B., WOLMARK, N., DRAKE, J.C., CHABNER, B.A. and ALLEGRA, C.J., The role of thymidylate-synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J. clin. Oncol. 12, 2640-2647 (1994).
10. LOWER, E.E. and WILLIAMS, L., Phosphotyrosine expression in breast-cancer specimens is associated with worse prognosis. Proc. Amer. Ass. Cancer Res., 33, 373 (1992).
11. O'NEILL, K.L., HOPER, M. and ODLING-SMEE, G.W., Can thymidine-kinase levels in breast tumours predict disease recurrence? J. nat. Cancer Inst., 84, 1825-1828 (1992).
12. RAEMARKERS, J.M.M., BEEX, L.V.A.M., PIETERS, G.F.F.M., SMALS, A.G.H., BENRAAD, TH.J., KLOPPENBORG, P.W.C. and THE BREAST-CANCER STUDY GROUP, Progesterone-receptor activity and relapse-free survival in patients with primary breast cancer: the role of adjuvant chemotherapy. Breast Cancer Res. Treat., 9, 191-199 (1987).
13. ROMAIN, S., CHINOT, O., KLIJN, J.G.M., VAN PUTTEN, W.L.J., GUIROU, O., LOOK, M., MARTIN, P.M. and FOEKENS, J.A., Prognostic value of cytosolic tyrosine-kinase activity in 249 node-positive breast-cancer patients. Brit. J. Cancer. 70, 304-308 (1994a).
14. ROMAIN, S., CHRISTENSEN, I.B.J., CHINOT, O., BALSLEV, I., ROSE, C., MARTIN, P.M. and THORPE, S.M., Prognostic value of cytosolic thymidine-kinase activity as a marker of proliferation in breast cancer. Int. J. Cancer, 61, 7-12 (1995).
15. ROMAIN, S., SPYRATOS, F., GUIROU, O., DEYTIEUX, S., CHINOT, O. and MARTIN, P.M., Technical evaluation of thymidine-kinase assay in cytosols from breast cancer. Europ. J. Cancer. 30A, 2163-2165 (1994b).
16. SAKAMOTO, S., EBUCHI, M. and IWAMA, T., Relative activities of thymdylate synthase and thymidine kinase in human mammary tumours. Anticancer Res., 13, 205-208 (1993).
17. SILVESTRINI, R., DAIDONE, M.G., DI FRONZO, G., MORABITO, A., VALAGUSSA, P. and BONADONNA, G., Prognostic implication of labelling index versus estrogens and tumour size in node-negative breast cancer. Breast Cancer Res. Treat., 7, 25-28 (1986).
18. 4 Pteglu assays. In: Y. Rustum and J.J. McGuire (eds.), The expanding role of folates and fluoropyrimidines in cancer chemotherapy, pp. 97-104, Plenum Press, New York (1988).
19. SPYRATOS, F., MARTIN, P.M., HACENE, K., ROMAIN, S., ANDRIEU, C., FERRERO-POUS, M., DEYTIEUX, S., LE DOUSSAL, V., TUBIANA-HULIN, M. and BRUNET, M., Multiparametric evaluation of biological prognostic factors in primary breast cancer. J. nat. Cancer Inst., 84, 1266-1272 (1992).
20. SWAIN, S.M., LIPPMAN, M.E., EGAN, E.F., DRAKE, J.C., STEINBERG, S.M. and ALLEGRA, C.J., Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer. J. clin. Oncol., 7, 890-899 (1995).
21. WAFFLART, J., DAVER, A., GRENIER, J., LEMIEUX, P., SIMONY-LAFONTAINE, J., ANGIBEAU, R.M., TROJANI, M. and RICHARD, C., Cytosolic thymidine-kinase activity as a marker of cell proliferation in primary breast cancer. Breast Cancer Res. Treat., 14 (Abstract 12), 135 (1989).